TreeWAS – Variant ID: rs1075496

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
K90.0 Coeliac disease	1.000	0.000	0.000
L40.9 Psoriasis, unspecified	1.000	0.000	0.000
L40 Psoriasis	0.999	0.001	0.000
L40.5 Arthropathic psoriasis	0.997	0.003	0.000
L40.0 Psoriasis vulgaris	0.879	0.121	0.000
K90 Intestinal malabsorption	0.841	0.159	0.000
L40.8 Other psoriasis	0.800	0.200	0.000
K90.4 Malabsorption due to intolerance, not elsewhere classified	0.794	0.206	0.000
L40.4 Guttate psoriasis	0.789	0.211	0.000
L40.1 Generalised pustular psoriasis	0.747	0.253	0.000
L40.2 Acrodermatitis continua	0.716	0.284	0.000
L40.3 Pustulosis palmaris et plantaris	0.685	0.315	0.000
K90.9 Intestinal malabsorption, unspecified	0.653	0.347	0.000
K90.8 Other intestinal malabsorption	0.624	0.376	0.000
K90.3 Pancreatic steatorrhoea	0.603	0.397	0.000
K90.2 Blind loop syndrome, not elsewhere classified	0.603	0.397	0.000
K90.1 Tropical sprue	0.603	0.397	0.000
L40-L45 Papulosquamous disorders	0.331	0.669	0.000
L44 Other papulosquamous disorders	0.237	0.763	0.000
L41 Parapsoriasis	0.237	0.763	0.000
L45 Papulosquamous disorders in diseases classified elsewhere	0.237	0.763	0.000
L43 Lichen planus	0.222	0.778	0.000
L42 Pityriasis rosea	0.213	0.787	0.000
L43.8 Other lichen planus	0.177	0.822	0.000
L41.9 Parapsoriasis, unspecified	0.170	0.830	0.000
L41.8 Other parapsoriasis	0.170	0.830	0.000
L41.5 Retiform parapsoriasis	0.170	0.830	0.000
L41.4 Large plaque parapsoriasis	0.170	0.830	0.000
L41.3 Small plaque parapsoriasis	0.170	0.830	0.000
L41.2 Lymphomatoid papulosis	0.170	0.830	0.000
L41.1 Pityriasis lichenoides chronica	0.170	0.830	0.000
L41.0 Pityriasis lichenoides et varioliformis acuta	0.170	0.830	0.000
L44.9 Papulosquamous disorder, unspecified	0.170	0.830	0.000
L44.8 Other specified papulosquamous disorders	0.170	0.830	0.000
L44.4 Infantile papular acrodermatitis [Giannotti-Crosti]	0.170	0.830	0.000
L44.3 Lichen ruber moniliformis	0.170	0.830	0.000
L44.2 Lichen striatus	0.170	0.830	0.000
L44.1 Lichen nitidus	0.170	0.830	0.000
L44.0 Pityriasis rubra pilaris	0.170	0.830	0.000
L43.3 Subacute (active) lichen planus	0.159	0.840	0.000
L43.2 Lichenoid drug reaction	0.159	0.840	0.000
L43.1 Bullous lichen planus	0.159	0.840	0.000
L43.0 Hypertrophic lichen planus	0.159	0.840	0.000
L43.9 Lichen planus, unspecified	0.113	0.887	0.000
E05.0 Thyrotoxicosis with diffuse goitre	0.097	0.903	0.000
E05 Thyrotoxicosis [hyperthyroidism]	0.091	0.909	0.000
E05.9 Thyrotoxicosis, unspecified	0.084	0.916	0.000
E00-E07 Disorders of thyroid gland	0.083	0.917	0.000
E03 Other hypothyroidism	0.082	0.918	0.000
E03.9 Hypothyroidism, unspecified	0.081	0.919	0.000
B18.2 Chronic viral hepatitis C	0.073	0.927	0.000
E03.8 Other specified hypothyroidism	0.070	0.930	0.000
E10-E14 Diabetes mellitus	0.070	0.930	0.000
E11 Non-insulin-dependent diabetes mellitus	0.069	0.931	0.000
E10.3 With ophthalmic complications	0.069	0.931	0.000
E11.6 With other specified complications	0.069	0.931	0.000
E10 Insulin-dependent diabetes mellitus	0.066	0.934	0.000
E11.1 With ketoacidosis	0.066	0.934	0.000
E05.5 Thyroid crisis or storm	0.065	0.935	0.000
E05.4 Thyrotoxicosis factitia	0.065	0.935	0.000
E05.3 Thyrotoxicosis from ectopic thyroid tissue	0.065	0.935	0.000
E05.1 Thyrotoxicosis with toxic single thyroid nodule	0.065	0.935	0.000
N18 Chronic renal failure	0.064	0.936	0.000
N18.4 Chronic kidney disease, stage 4	0.063	0.937	0.000
Chapter IV Endocrine, nutritional and metabolic diseases	0.063	0.937	0.000
E02 Subclinical iodine-deficiency hypothyroidism	0.063	0.937	0.000
E05.8 Other thyrotoxicosis	0.063	0.937	0.000
N18.5 Chronic kidney disease, stage 5	0.063	0.937	0.000
N18.9 Chronic renal failure, unspecified	0.063	0.937	0.000
E03.2 Hypothyroidism due to medicaments and other exogenous substances	0.063	0.937	0.000
E11.0 With coma	0.062	0.938	0.000
E10.2 With renal complications	0.062	0.938	0.000
E03.0 Congenital hypothyroidism with diffuse goitre	0.061	0.939	0.000
E01 Iodine-deficiency-related thyroid disorders and allied conditions	0.059	0.941	0.000
E00 Congenital iodine-deficiency syndrome	0.059	0.941	0.000
E06 Thyroiditis	0.059	0.941	0.000
E03.5 Myxoedema coma	0.059	0.941	0.000
E03.4 Atrophy of thyroid (acquired)	0.059	0.941	0.000
E03.3 Postinfectious hypothyroidism	0.059	0.941	0.000
E11.2 With renal complications	0.057	0.943	0.000
N18.1 Chronic kidney disease, stage 1	0.057	0.943	0.000
E11.7 With multiple complications	0.057	0.943	0.000
K90-K93 Other diseases of the digestive system	0.057	0.943	0.000
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion	0.056	0.943	0.000
E14 Unspecified diabetes mellitus	0.055	0.945	0.000
E11.5 With peripheral circulatory complications	0.055	0.945	0.000
N18.0 End-stage renal disease	0.054	0.946	0.000
E07 Other disorders of thyroid	0.053	0.947	0.000
E16 Other disorders of pancreatic internal secretion	0.052	0.948	0.000
E12 Malnutrition-related diabetes mellitus	0.050	0.950	0.000
N18.8 Other chronic renal failure	0.050	0.950	0.000
E06.9 Thyroiditis, unspecified	0.050	0.950	0.000
E10.7 With multiple complications	0.049	0.951	0.000
B18 Chronic viral hepatitis	0.048	0.952	0.000
E40-E46 Malnutrition	0.048	0.952	0.000
E14.3 With ophthalmic complications	0.048	0.952	0.000
E16.2 Hypoglycaemia, unspecified	0.048	0.952	0.000
E03.1 Congenital hypothyroidism without goitre	0.047	0.953	0.000
E13 Other specified diabetes mellitus	0.046	0.954	0.000
E10.9 Without complications	0.046	0.954	0.000
E05.2 Thyrotoxicosis with toxic multinodular goitre	0.045	0.955	0.000
E10.4 With neurological complications	0.045	0.955	0.000
E14.1 With ketoacidosis	0.043	0.957	0.000
E10.1 With ketoacidosis	0.043	0.957	0.000
E14.2 Withrenal complications	0.043	0.957	0.000
E00.9 Congenital iodine-deficiency syndrome, unspecified	0.043	0.957	0.000
E00.2 Congenital iodine-deficiency syndrome, mixed type	0.043	0.957	0.000
E00.1 Congenital iodine-deficiency syndrome, myxoedematous type	0.043	0.957	0.000
E00.0 Congenital iodine-deficiency syndrome, neurological type	0.043	0.957	0.000
E01.8 Other iodine-deficiency-related thyroid disorders and allied conditions	0.043	0.957	0.000
E01.2 Iodine-deficiency-related (endemic) goitre, unspecified	0.043	0.957	0.000
E01.1 Iodine-deficiency-related multinodular (endemic) goitre	0.043	0.957	0.000
E01.0 Iodine-deficiency-related diffuse (endemic) goitre	0.043	0.957	0.000
E06.4 Drug-induced thyroiditis	0.043	0.957	0.000
E06.2 Chronic thyroiditis with transient thyrotoxicosis	0.043	0.957	0.000
E06.0 Acute thyroiditis	0.043	0.957	0.000
E06.5 Other chronic thyroiditis	0.043	0.957	0.000
E16.0 Drug-induced hypoglycaemia without coma	0.042	0.957	0.000
E14.4 With neurological complications	0.042	0.957	0.000
E07.8 Other specified disorders of thyroid	0.042	0.958	0.000
E14.8 With unspecified complications	0.042	0.958	0.000
E14.0 With coma	0.042	0.958	0.000
K93 Disorders of other digestive organs in diseases classified elsewhere	0.041	0.959	0.000
E15 Nondiabetic hypoglycaemic coma	0.041	0.959	0.000
E10.6 With other specified complications	0.041	0.959	0.000
E06.1 Subacute thyroiditis	0.040	0.960	0.000
E11.3 With ophthalmic complications	0.040	0.960	0.000
E14.5 With peripheral circulatory complications	0.040	0.960	0.000
E14.7 With multiple complications	0.040	0.960	0.000
E10.5 With peripheral circulatory complications	0.038	0.962	0.000
E07.1 Dyshormogenetic goitre	0.038	0.962	0.000
E07.0 Hypersecretion of calcitonin	0.038	0.962	0.000
B18.9 Chronic viral hepatitis, unspecified	0.038	0.962	0.000
E16.9 Disorder of pancreatic internal secretion, unspecified	0.037	0.963	0.000
E16.8 Other specified disorders of pancreatic internal secretion	0.037	0.963	0.000
E16.4 Abnormal secretion of gastrin	0.037	0.963	0.000
E16.3 Increased secretion of glucagon	0.037	0.963	0.000
E13.3 With ophthalmic complications	0.037	0.963	0.000
E46 Unspecified protein-energy malnutrition	0.037	0.963	0.000
E12.9 Without complications	0.036	0.964	0.000
E12.8 With unspecified complications	0.036	0.964	0.000
E12.7 With multiple complications	0.036	0.964	0.000
E12.6 With other specified complications	0.036	0.964	0.000
E12.5 With peripheral circulatory complications	0.036	0.964	0.000
E12.4 With neurological complications	0.036	0.964	0.000
E12.3 With ophthalmic complications	0.036	0.964	0.000
E12.2 With renal complications	0.036	0.964	0.000
E12.1 With ketoacidosis	0.036	0.964	0.000
E12.0 With coma	0.036	0.964	0.000
E11.8 With unspecified complications	0.035	0.965	0.000
E16.1 Other hypoglycaemia	0.035	0.965	0.000
E50-E64 Other nutritional deficiencies	0.035	0.965	0.000
B18.8 Other chronic viral hepatitis	0.035	0.965	0.000
B18.0 Chronic viral hepatitis B with delta-agent	0.035	0.965	0.000
E06.3 Autoimmune thyroiditis	0.035	0.965	0.000
E44 Protein-energy malnutrition of moderate and mild degree	0.034	0.965	0.000
E45 Retarded development following protein-energy malnutrition	0.034	0.965	0.000
E43 Unspecified severe protein-energy malnutrition	0.034	0.965	0.000
E42 Marasmic kwashiorkor	0.034	0.965	0.000
E41 Nutritional marasmus	0.034	0.965	0.000
E40 Kwashiorkor	0.034	0.965	0.000
R31 Unspecified haematuria	0.000	0.966	0.034
N18.3 Chronic kidney disease, stage 3	0.034	0.966	0.000
E13.8 With unspecified complications	0.033	0.966	0.000
E13.7 With multiple complications	0.033	0.966	0.000
E13.6 With other specified complications	0.033	0.966	0.000
E13.5 With peripheral circulatory complications	0.033	0.966	0.000
E13.4 With neurological complications	0.033	0.966	0.000
E13.2 With renal complications	0.033	0.966	0.000
E13.1 With ketoacidosis	0.033	0.966	0.000
E13.0 With coma	0.033	0.966	0.000
E10.0 With coma	0.032	0.967	0.000
E14.6 With other specified complications	0.032	0.968	0.000
E10.8 With unspecified complications	0.031	0.969	0.000
E51 Thiamine deficiency	0.031	0.969	0.000
B15-B19 Viral hepatitis	0.030	0.970	0.000
B18.1 Chronic viral hepatitis B without delta-agent	0.030	0.970	0.000
K93.8 Disorders of other specified digestive organs in diseases classified elsewhere	0.029	0.970	0.000
K93.1 Megacolon in Chagas' disease	0.029	0.970	0.000
K93.0 Tuberculous disorders of intestines, peritoneum and mesenteric glands	0.029	0.970	0.000
E51.2 Wernicke's encephalopathy	0.028	0.972	0.000
B17 Other acute viral hepatitis	0.028	0.972	0.000
E20-E35 Disorders of other endocrine glands	0.027	0.973	0.000
B17.1 Acute hepatitis C	0.026	0.974	0.000
E23 Hypofunction and other disorders of pituitary gland	0.026	0.974	0.000
E56 Other vitamin deficiencies	0.026	0.974	0.000
B16 Acute hepatitis B	0.025	0.974	0.000
E64 Sequelae of malnutrition and other nutritional deficiencies	0.025	0.975	0.000
E63 Other nutritional deficiencies	0.025	0.975	0.000
E50 Vitamin A deficiency	0.025	0.975	0.000
E60 Dietary zinc deficiency	0.025	0.975	0.000
E59 Dietary selenium deficiency	0.025	0.975	0.000
E54 Ascorbic acid deficiency	0.025	0.975	0.000
E52 Niacin deficiency [pellagra]	0.025	0.975	0.000
E44.1 Mild protein-energy malnutrition	0.025	0.975	0.000
E44.0 Moderate protein-energy malnutrition	0.025	0.975	0.000
E58 Dietary calcium deficiency	0.025	0.975	0.000
E07.9 Disorder of thyroid, unspecified	0.025	0.975	0.000
E23.2 Diabetes insipidus	0.024	0.976	0.000
E24 Cushing's syndrome	0.023	0.977	0.000
E65-E68 Obesity and other hyperalimentation	0.023	0.977	0.000
N11.9 Chronic tubulo-interstitial nephritis, unspecified	0.023	0.977	0.000
E23.7 Disorder of pituitary gland, unspecified	0.023	0.977	0.000
E13.9 Without complications	0.023	0.977	0.000
E51.9 Thiamine deficiency, unspecified	0.022	0.978	0.000
E51.8 Other manifestations of thiamine deficiency	0.022	0.978	0.000
E51.1 Beriberi	0.022	0.978	0.000
M35.0 Sicca syndrome [Sjogren]	0.022	0.978	0.000
B16.9 Acute hepatitis B without delta-agent and without hepatic coma	0.022	0.978	0.000
E23.6 Other disorders of pituitary gland	0.021	0.979	0.000
E21 Hyperparathyroidism and other disorders of parathyroid gland	0.021	0.979	0.000
E25 Adrenogenital disorders	0.021	0.979	0.000
B17.2 Acute hepatitis E	0.021	0.979	0.000
B17.9 Acute viral hepatitis, unspecified	0.020	0.980	0.000
B17.0 Acute delta-(super) infection of hepatitis B carrier	0.020	0.980	0.000
B15 Acute hepatitis A	0.020	0.980	0.000
E24.0 Pituitary-dependent Cushing's disease	0.020	0.980	0.000
N11 Chronic tubulo-interstitial nephritis	0.019	0.980	0.000
E35 Disorders of endocrine glands in diseases classified elsewhere	0.019	0.981	0.000
E32 Diseases of thymus	0.019	0.981	0.000
E30 Disorders of puberty, not elsewhere classified	0.019	0.981	0.000
E56.1 Deficiency of vitamin K	0.019	0.981	0.000
E31 Polyglandular dysfunction	0.019	0.981	0.000
B17.8 Other specified acute viral hepatitis	0.019	0.981	0.000
E21.0 Primary hyperparathyroidism	0.019	0.981	0.000
E23.3 Hypothalamic dysfunction, not elsewhere classified	0.019	0.981	0.000
E23.1 Drug-induced hypopituitarism	0.019	0.981	0.000
E61 Deficiency of other nutrient elements	0.019	0.981	0.000
E56.9 Vitamin deficiency, unspecified	0.019	0.981	0.000
E56.8 Deficiency of other vitamins	0.019	0.981	0.000
E56.0 Deficiency of vitamin E	0.019	0.981	0.000
B16.2 Acute hepatitis B without delta-agent with hepatic coma	0.018	0.981	0.000
B16.1 Acute hepatitis B with delta-agent (coinfection) without hepatic coma	0.018	0.981	0.000
B16.0 Acute hepatitis B with delta-agent (coinfection) with hepatic coma	0.018	0.981	0.000
E50.9 Vitamin A deficiency, unspecified	0.018	0.982	0.000
E50.8 Other manifestations of vitamin A deficiency	0.018	0.982	0.000
E50.7 Other ocular manifestations of vitamin A deficiency	0.018	0.982	0.000
E50.6 Vitamin A deficiency with xerophthalmic scars of cornea	0.018	0.982	0.000
E50.5 Vitamin A deficiency with night blindness	0.018	0.982	0.000
E50.4 Vitamin A deficiency with keratomalacia	0.018	0.982	0.000
E50.3 Vitamin A deficiency with corneal ulceration and xerosis	0.018	0.982	0.000
E50.2 Vitamin A deficiency with corneal xerosis	0.018	0.982	0.000
E50.1 Vitamin A deficiency with Bitot's spot and conjunctival xerosis	0.018	0.982	0.000
E50.0 Vitamin A deficiency with conjunctival xerosis	0.018	0.982	0.000
E63.9 Nutritional deficiency, unspecified	0.018	0.982	0.000
E63.8 Other specified nutritional deficiencies	0.018	0.982	0.000
E63.1 Imbalance of constituents of food intake	0.018	0.982	0.000
E63.0 Essential fatty acid [EFA] deficiency	0.018	0.982	0.000
E64.9 Sequelae of unspecified nutritional deficiency	0.018	0.982	0.000
E64.8 Sequelae of other nutritional deficiencies	0.018	0.982	0.000
E64.3 Sequelae of rickets	0.018	0.982	0.000
E64.2 Sequelae of vitamin C deficiency	0.018	0.982	0.000
E64.1 Sequelae of vitamin A deficiency	0.018	0.982	0.000
E64.0 Sequelae of protein-energy malnutrition	0.018	0.982	0.000
E14.9 Without complications	0.018	0.982	0.000
E24.8 Other Cushing's syndrome	0.018	0.982	0.000
E24.9 Cushing's syndrome, unspecified	0.018	0.982	0.000
E55 Vitamin D deficiency	0.018	0.982	0.000
E26 Hyperaldosteronism	0.018	0.982	0.000
E24.2 Drug-induced Cushing's syndrome	0.017	0.983	0.000
E53 Deficiency of other B group vitamins	0.017	0.983	0.000
E25.0 Congenital adrenogenital disorders associated with enzyme deficiency	0.017	0.983	0.000
E24.4 Alcohol-induced pseudo-Cushing's syndrome	0.017	0.983	0.000
E24.3 Ectopic ACTH syndrome	0.017	0.983	0.000
E24.1 Nelson's syndrome	0.017	0.983	0.000
B19 Unspecified viral hepatitis	0.017	0.983	0.000
E67 Other hyperalimentation	0.017	0.983	0.000
E68 Sequelae of hyperalimentation	0.017	0.983	0.000
E21.5 Disorder of parathyroid gland, unspecified	0.017	0.983	0.000
H43.1 Vitreous haemorrhage	0.017	0.983	0.000
N10 Acute tubulo-interstitial nephritis	0.017	0.983	0.000
E21.4 Other specified disorders of parathyroid gland	0.017	0.983	0.000
E83.1 Disorders of iron metabolism	0.000	0.984	0.016
E23.0 Hypopituitarism	0.016	0.984	0.000
N11.1 Chronic obstructive pyelonephritis	0.016	0.984	0.000
E20 Hypoparathyroidism	0.015	0.984	0.000
E25.9 Adrenogenital disorder, unspecified	0.015	0.985	0.000
E25.8 Other adrenogenital disorders	0.015	0.985	0.000
N10-N16 Renal tubulo-interstitial diseases	0.015	0.985	0.000
E21.1 Secondary hyperparathyroidism, not elsewhere classified	0.015	0.985	0.000
N11.0 Nonobstructive reflux-associated chronic pyelonephritis	0.015	0.985	0.000
B15.0 Hepatitis A with hepatic coma	0.014	0.985	0.000
N11.8 Other chronic tubulo-interstitial nephritis	0.014	0.986	0.000
N18.2 Chronic kidney disease, stage 2	0.014	0.986	0.000
E30.9 Disorder of puberty, unspecified	0.014	0.986	0.000
E30.8 Other disorders of puberty	0.014	0.986	0.000
E30.1 Precocious puberty	0.014	0.986	0.000
E30.0 Delayed puberty	0.014	0.986	0.000
E32.9 Disease of thymus, unspecified	0.014	0.986	0.000
E32.8 Other diseases of thymus	0.014	0.986	0.000
E32.1 Abscess of thymus	0.014	0.986	0.000
E32.0 Persistent hyperplasia of thymus	0.014	0.986	0.000
E35.8 Disorders of other endocrine glands in diseases classified elsewhere	0.014	0.986	0.000
E35.1 Disorders of adrenal glands in diseases classified elsewhere	0.014	0.986	0.000
E35.0 Disorders of thyroid gland in diseases classified elsewhere	0.014	0.986	0.000
E21.2 Other hyperparathyroidism	0.014	0.986	0.000
E31.9 Polyglandular dysfunction, unspecified	0.014	0.986	0.000
E31.8 Other polyglandular dysfunction	0.014	0.986	0.000
E31.1 Polyglandular hyperfunction	0.014	0.986	0.000
E31.0 Autoimmune polyglandular failure	0.014	0.986	0.000
E61.9 Deficiency of nutrient element, unspecified	0.014	0.986	0.000
E61.8 Deficiency of other specified nutrient elements	0.014	0.986	0.000
E61.7 Deficiency of multiple nutrient elements	0.014	0.986	0.000
E61.6 Vanadium deficiency	0.014	0.986	0.000
E61.5 Molybdenum deficiency	0.014	0.986	0.000
E61.4 Chromium deficiency	0.014	0.986	0.000
E61.3 Manganese deficiency	0.014	0.986	0.000
E61.0 Copper deficiency	0.014	0.986	0.000
E29 Testicular dysfunction	0.013	0.986	0.000
E61.2 Magnesium deficiency	0.013	0.987	0.000
Z76.9 Persons encountering health services in unspecified circumstances	0.000	0.987	0.013
E55.0 Rickets, active	0.013	0.987	0.000
E26.8 Other hyperaldosteronism	0.013	0.987	0.000
E26.1 Secondary hyperaldosteronism	0.013	0.987	0.000
E26.9 Hyperaldosteronism, unspecified	0.013	0.987	0.000
E53.1 Pyridoxine deficiency	0.013	0.987	0.000
E53.0 Riboflavin deficiency	0.013	0.987	0.000
E65 Localised adiposity	0.013	0.987	0.000
B19.0 Unspecified viral hepatitis with coma	0.012	0.987	0.000
E67.8 Other specified hyperalimentation	0.012	0.988	0.000
E67.3 Hypervitaminosis D	0.012	0.988	0.000
E67.2 Megavitamin-B6 syndrome	0.012	0.988	0.000
E67.1 Hypercarotenaemia	0.012	0.988	0.000
E67.0 Hypervitaminosis A	0.012	0.988	0.000
E53.9 Vitamin B deficiency, unspecified	0.012	0.988	0.000
H43 Disorders of vitreous body	0.012	0.988	0.000
E34 Other endocrine disorders	0.012	0.988	0.000
B15.9 Hepatitis A without hepatic coma	0.012	0.988	0.000
E11.4 With neurological complications	0.012	0.988	0.000
N14 Drug- and heavy-metal-induced tubulo-interstitial and tubular conditions	0.012	0.988	0.000
E28 Ovarian dysfunction	0.012	0.988	0.000
E20.8 Other hypoparathyroidism	0.011	0.988	0.000
E20.1 Pseudohypoparathyroidism	0.011	0.988	0.000
E20.0 Idiopathic hypoparathyroidism	0.011	0.988	0.000
E26.0 Primary hyperaldosteronism	0.011	0.989	0.000
N16 Renal tubulo-interstitial disorders in diseases classified elsewhere	0.011	0.989	0.000
E22 Hyperfunction of pituitary gland	0.011	0.989	0.000
E21.3 Hyperparathyroidism, unspecified	0.011	0.989	0.000
K91 Postprocedural disorders of digestive system, not elsewhere classified	0.011	0.989	0.000
H43.2 Crystalline deposits in vitreous body	0.010	0.990	0.000
N14.1 Nephropathy induced by other drugs, medicaments and biological substances	0.010	0.990	0.000
E29.9 Testicular dysfunction, unspecified	0.010	0.990	0.000
E29.8 Other testicular dysfunction	0.010	0.990	0.000
E29.0 Testicular hyperfunction	0.010	0.990	0.000
H43.3 Other vitreous opacities	0.010	0.990	0.000
H43.8 Other disorders of vitreous body	0.010	0.990	0.000
H43.9 Disorder of vitreous body, unspecified	0.010	0.990	0.000
N15 Other renal tubulo-interstitial diseases	0.009	0.990	0.000
K91.9 Postprocedural disorder of digestive system, unspecified	0.009	0.991	0.000
E34.3 Short stature, not elsewhere classified	0.009	0.991	0.000
K91.1 Postgastric surgery syndromes	0.009	0.991	0.000
N17-N19 Renal failure	0.009	0.991	0.000
N13.2 Hydronephrosis with renal and ureteral calculous obstruction	0.009	0.991	0.000
H43.0 Vitreous prolapse	0.009	0.991	0.000
Z76 Persons encountering health services in other circumstances	0.000	0.991	0.009
E34.5 Androgen resistance syndrome	0.009	0.991	0.000
E34.4 Constitutional tall stature	0.009	0.991	0.000
E34.2 Ectopic hormone secretion, not elsewhere classified	0.009	0.991	0.000
E34.1 Other hypersecretion of intestinal hormones	0.009	0.991	0.000
N14.4 Toxic nephropathy, not elsewhere classified	0.009	0.991	0.000
N14.3 Nephropathy induced by heavy metals	0.009	0.991	0.000
N14.2 Nephropathy induced by unspecified drug, medicament or biological substance	0.009	0.991	0.000
N14.0 Analgesic nephropathy	0.009	0.991	0.000
Z76.3 Healthy person accompanying sick person	0.000	0.991	0.009
E27 Other disorders of adrenal gland	0.009	0.991	0.000
E28.9 Ovarian dysfunction, unspecified	0.009	0.991	0.000
E28.8 Other ovarian dysfunction	0.009	0.991	0.000
E28.1 Androgen excess	0.009	0.991	0.000
E28.0 Oestrogen excess	0.009	0.991	0.000
N13 Obstructive and reflux uropathy	0.009	0.991	0.000
M35 Other systemic involvement of connective tissue	0.009	0.991	0.000
K91.2 Postsurgical malabsorption, not elsewhere classified	0.008	0.992	0.000
N16.8 Renal tubulo-interstitial disorders in other diseases classified elsewhere	0.008	0.992	0.000
N16.5 Renal tubulo-interstitial disorders in transplant rejection	0.008	0.992	0.000
N16.4 Renal tubulo-interstitial disorders in systemic connective tissue disorders	0.008	0.992	0.000
N16.3 Renal tubulo-interstitial disorders in metabolic diseases	0.008	0.992	0.000
N16.2 Renal tubulo-interstitial disorders in blood diseases and disorders involving the immune mechanism	0.008	0.992	0.000
N16.1 Renal tubulo-interstitial disorders in neoplastic diseases	0.008	0.992	0.000
N16.0 Renal tubulo-interstitial disorders in infectious and parasitic diseases classified elsewhere	0.008	0.992	0.000
N12 Tubulo-interstitial nephritis, not specified as acute or chronic	0.008	0.992	0.000
E22.9 Hyperfunction of pituitary gland, unspecified	0.008	0.992	0.000
E22.8 Other hyperfunction of pituitary gland	0.008	0.992	0.000
V89.2 Person injured in unspecified motor-vehicle accident, traffic	0.000	0.992	0.008
N13.1 Hydronephrosis with ureteral stricture, not elsewhere classified	0.008	0.992	0.000
E27.3 Drug-induced adrenocortical insufficiency	0.008	0.992	0.000
M35.7 Hypermobility syndrome	0.008	0.992	0.000
E20.9 Hypoparathyroidism, unspecified	0.007	0.992	0.000
E61.1 Iron deficiency	0.008	0.992	0.000
E28.3 Primary ovarian failure	0.007	0.992	0.000
B19.9 Unspecified viral hepatitis without coma	0.007	0.992	0.001
E34.9 Endocrine disorder, unspecified	0.007	0.992	0.000
E22.1 Hyperprolactinaemia	0.007	0.992	0.000
K91.0 Vomiting following gastro-intestinal surgery	0.007	0.992	0.000
O30.0 Twin pregnancy	0.000	0.993	0.007
E34.8 Other specified endocrine disorders	0.007	0.993	0.000
E34.0 Carcinoid syndrome	0.007	0.993	0.000
N15.8 Other specified renal tubulo-interstitial diseases	0.007	0.993	0.000
N15.0 Balkan nephropathy	0.007	0.993	0.000
Z76.5 Malingerer [conscious situation]	0.000	0.993	0.007
Z76.4 Other boarder in health-care facility	0.000	0.993	0.007
Z76.2 Health supervision and care of other healthy infant and child	0.000	0.993	0.007
Z76.1 Health supervision and care of foundling	0.000	0.993	0.007
Z76.0 Issue of repeat prescription	0.000	0.993	0.007
M35.2 Behcet's disease	0.007	0.993	0.000
M35.8 Other specified systemic involvement of connective tissue	0.007	0.993	0.000
E27.5 Adrenomedullary hyperfunction	0.006	0.993	0.000
E27.0 Other adrenocortical overactivity	0.006	0.993	0.000
N13.0 Hydronephrosis with ureteropelvic junction obstruction	0.007	0.993	0.000
E27.4 Other and unspecified adrenocortical insufficiency	0.006	0.993	0.000
Z76.8 Persons encountering health services in other specified circumstances	0.000	0.993	0.006
M35.9 Systemic involvement of connective tissue, unspecified	0.006	0.994	0.000
M35.6 Relapsing panniculitis [Weber-Christian]	0.006	0.994	0.000
M35.5 Multifocal fibrosclerosis	0.006	0.994	0.000
M35.4 Diffuse (eosinophilic) fasciitis	0.006	0.994	0.000
N15.1 Renal and perinephric abscess	0.006	0.994	0.000
N15.9 Renal tubulo-interstitial disease, unspecified	0.006	0.994	0.000
N13.6 Pyonephrosis	0.006	0.994	0.000
N04.9 Unspecified	0.006	0.994	0.000
E04 Other non-toxic goitre	0.006	0.994	0.000
K91.5 Postcholecystectomy syndrome	0.006	0.994	0.000
N13.9 Obstructive and reflux uropathy, unspecified	0.006	0.994	0.000
E22.2 Syndrome of inappropriate secretion of antidiuretic hormone	0.006	0.994	0.000
M05.99 Seropositive rheumatoid arthritis, unspecified (Site unspecified)	0.000	0.994	0.006
E11.9 Without complications	0.006	0.994	0.000
M35.1 Other overlap syndromes	0.006	0.994	0.000
N04 Nephrotic syndrome	0.006	0.994	0.000
E66 Obesity	0.006	0.994	0.000
M05.90 Seropositive rheumatoid arthritis, unspecified (Multiple sites)	0.000	0.994	0.006
E53.8 Deficiency of other specified B group vitamins	0.006	0.994	0.000
M05.9 Seropositive rheumatoid arthritis, unspecified	0.000	0.994	0.006
E27.1 Primary adrenocortical insufficiency	0.006	0.994	0.000
E55.9 Vitamin D deficiency, unspecified	0.006	0.994	0.000
S00.9 Superficial injury of head, part unspecified	0.000	0.994	0.006
E22.0 Acromegaly and pituitary gigantism	0.005	0.994	0.000
M23.33 Other meniscus derangements (Medial collateral ligament or Other and unspecified medial meniscus)	0.005	0.995	0.000
N04.1 Focal and segmental glomerular lesions	0.005	0.995	0.000
N17 Acute renal failure	0.005	0.995	0.000
N13.4 Hydroureter	0.005	0.995	0.000
N17.8 Other acute renal failure	0.005	0.995	0.000
M06.90 Rheumatoid arthritis, unspecified (Multiple sites)	0.000	0.995	0.005
N05.1 Focal and segmental glomerular lesions	0.005	0.995	0.000
N13.7 Vesicoureteral-reflux-associated uropathy	0.005	0.995	0.000
M79.63 Pain in limb (Forearm)	0.005	0.995	0.000
M35.99 Systemic involvement of connective tissue, unspecified, Site unspecified	0.005	0.995	0.000
N13.5 Kinking and stricture of ureter without hydronephrosis	0.005	0.995	0.000
E66.0 Obesity due to excess calories	0.005	0.995	0.000
E27.2 Addisonian crisis	0.005	0.995	0.000
K62.8 Other specified diseases of anus and rectum	0.000	0.995	0.005
K51 Ulcerative colitis	0.000	0.995	0.005
E04.8 Other specified non-toxic goitre	0.005	0.995	0.000
N00-N08 Glomerular diseases	0.005	0.995	0.000
N04.2 Diffuse membranous glomerulonephritis	0.005	0.995	0.000
M05.92 Seropositive rheumatoid arthritis, unspecified (Upper arm)	0.000	0.995	0.005
N05 Unspecified nephritic syndrome	0.005	0.995	0.000
K51.0 Ulcerative (chronic) enterocolitis	0.000	0.995	0.005
M05.96 Seropositive rheumatoid arthritis, unspecified (Lower leg)	0.000	0.995	0.005
K91.3 Postoperative intestinal obstruction	0.005	0.995	0.000
N08.3 Glomerular disorders in diabetes mellitus	0.005	0.995	0.000
M05.94 Seropositive rheumatoid arthritis, unspecified (Hand)	0.000	0.995	0.005
K51.5 Mucosal proctocolitis	0.000	0.995	0.004
N08 Glomerular disorders in diseases classified elsewhere	0.004	0.996	0.000
E27.9 Disorder of adrenal gland, unspecified	0.004	0.996	0.000
N04.8 Other	0.004	0.996	0.000
N04.7 Diffuse crescentic glomerulonephritis	0.004	0.996	0.000
N04.6 Dense deposit disease	0.004	0.996	0.000
N04.5 Diffuse mesangiocapillary glomerulonephritis	0.004	0.996	0.000
N04.4 Diffuse endocapillary proliferative glomerulonephritis	0.004	0.996	0.000
N04.3 Diffuse mesangial proliferative glomerulonephritis	0.004	0.996	0.000
D70 Agranulocytosis	0.004	0.996	0.000
E66.1 Drug-induced obesity	0.004	0.996	0.000
K51.3 Ulcerative (chronic) rectosigmoiditis	0.000	0.996	0.004
K51.4 Pseudopolyposis of colon	0.000	0.996	0.004
M05.97 Seropositive rheumatoid arthritis, unspecified (Ankle and foot)	0.000	0.996	0.004
M05.98 Seropositive rheumatoid arthritis, unspecified (Other)	0.000	0.996	0.004
M05.93 Seropositive rheumatoid arthritis, unspecified (Forearm)	0.000	0.996	0.004
M05.95 Seropositive rheumatoid arthritis, unspecified (Pelvic region and thigh)	0.000	0.996	0.004
E04.0 Non-toxic diffuse goitre	0.004	0.996	0.000
K51.8 Other ulcerative colitis	0.000	0.996	0.004
V18.0 Driver injured in nontraffic accident	0.000	0.996	0.004
N17.1 Acute renal failure with acute cortical necrosis	0.004	0.996	0.000
M05.91 Seropositive rheumatoid arthritis, unspecified (Shoulder region)	0.000	0.996	0.004
H47.2 Optic atrophy	0.004	0.996	0.000
D23.1 Skin of eyelid, including canthus	0.000	0.996	0.004
E29.1 Testicular hypofunction	0.004	0.996	0.001
N04.0 Minor glomerular abnormality	0.004	0.996	0.000
N00 Acute nephritic syndrome	0.004	0.996	0.000
N17.2 Acute renal failure with medullary necrosis	0.004	0.996	0.000
N05.2 Diffuse membranous glomerulonephritis	0.004	0.996	0.000
W07.0 Home	0.000	0.996	0.004
N05.5 Diffuse mesangiocapillary glomerulonephritis	0.004	0.996	0.000
K51.2 Ulcerative (chronic) proctitis	0.000	0.996	0.004
E28.2 Polycystic ovarian syndrome	0.004	0.996	0.000
T18.1 Foreign body in oesophagus	0.004	0.996	0.000
N87.9 Dysplasia of cervix uteri, unspecified	0.000	0.996	0.004
R23.3 Spontaneous ecchymoses	0.004	0.996	0.000
E66.2 Extreme obesity with alveolar hypoventilation	0.004	0.996	0.000
N13.8 Other obstructive and reflux uropathy	0.004	0.996	0.000
N07 Hereditary nephropathy, not elsewhere classified	0.004	0.996	0.000
N06 Isolated proteinuria with specified morphological lesion	0.004	0.996	0.000
N01 Rapidly progressive nephritic syndrome	0.004	0.996	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations